whitepaper
Application note: Oxidative Stress Measurements Made Easy
The advantages of detection of oxidative stress by high content analysis.
List view / Grid view
Drug Discovery Processes
Filter the results
whitepaper
Application note: Understanding Cell Death by High Content Analysis
Cell death is a process that occurs as both a part of normal tissue homeostasis and can be aberrantly regulated in some disease states, specifically cancer.
news
Fruit fly model for studying uric acid diseases developed
Researchers have created a fruit fly model to investigate uric acid-related diseases such as diabetes to aid in drug development.
whitepaper
Application Note: Ultra-sensitive Homebrew Assay
Biomarker detection at ultra-sensitive levels, using your own proprietary antibodies
whitepaper
Application note: Monitoring Aggregation of Antibody-Drug Conjugates
30 July 2019 | By
Prediction of Aggregation Propensity and Monitoring of Aggregation of Antibody-Drug Conjugates (ADC).
article
Encouraging drug discovery and therapeutic targets for dementia
A review has been published by experts in neurodegeneration research, detailing six ways to improve dementia research. This article investigates one of these suggestions, focusing on how we can improve drug target identification.
product
Intellicyt iQue3 – Faster, Smarter Flow Cytometry
This advanced flow cytometry platform is a complete instrument, reagents and software solution streamlined to rapidly generate results not just data.
article
Artificial intelligence in the world of drug discovery
Charlotte Walker-Osborn, a Partner and Head of Technology Sector (International) at global law-firm Eversheds Sutherland and a legal expert in technology law, explains some of the challenges and potential future of artificial intelligence (AI) in the field of drug discovery.
video
Video: Ethical and regulatory use of biospecimens in the EU
Unique considerations surrounding the bureaucracy and oversight in the use of human biospecimens in the European Union.
video
Video: Multiplex IHC and digital analysis for immuno-oncology
High content data derived for complex immuno-oncology research facilitates a deeper understanding of the tissue microenvironment.
article
Screening In-Depth Focus 2019
This in-depth focus discusses screening and the uses of phenotypic profiling in drug discovery. Also examined is the role that CRISPR/Cas9 gene editing and native mass spectrometry play.
whitepaper
Whitepaper: Cubis® II pharma compliant by design
Sartorius Cubis® II is designed to follow US FDA data integrity principles that require data to be accurate, legible, contemporaneous, original and attributable.
webinar
A high-throughput approach to developing T-cell immunotherapies
23 May 2019 | By Sartorius
Join us as we discuss the promises and pitfalls associated with developing individualised antigen-specific T-cell therapy products for clinical use.